SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-030908
Filing Date
2021-12-09
Accepted
2021-12-09 10:47:06
Documents
12
Period of Report
2021-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34114
  Complete submission text file 0001493152-21-030908.txt   202838

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eltp-20211209.xsd EX-101.SCH 3034
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eltp-20211209_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eltp-20211209_pre.xml EX-101.PRE 22365
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3391
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 211480793
SIC: 2834 Pharmaceutical Preparations